Transcriptome-based NGS outperforms traditional viral testing with superior sensitivity, detecting viruses including novel ...
UK-based DefiniGEN has developed iPSC-derived cell lines that can replace primary human hepatocytes for toxicity testing and accelerate the development of novel liver-targeted therapeutics. Drugmakers ...
STEMart, a US-based provider of comprehensive services for all phases of medical device development, has announced the availability of its robust In Vitro Micronucleus Test service to meet the ...
Recent advances in immunotherapy, targeted therapies, and gene therapies have significantly improved survival rates for ...
A recent article in Small highlights a new method for studying tumor cell interactions and testing anti-metastatic drugs ...
Addressing for the first time the issue of whether bioequivalence data and in vitro testing can show that an abbreviated new drug application (ANDA) product with different immediate and delayed ...